79 related articles for article (PubMed ID: 20477170)
1. Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease.
Moretti M
Expert Rev Respir Med; 2007 Dec; 1(3):307-16. PubMed ID: 20477170
[TBL] [Abstract][Full Text] [Related]
2. The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE Study.
Moretti M; Bottrighi P; Dallari R; Da Porto R; Dolcetti A; Grandi P; Garuti G; Guffanti E; Roversi P; De Gugliemo M; Potena A;
Drugs Exp Clin Res; 2004; 30(4):143-52. PubMed ID: 15553660
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study).
Marchioni CF; Polu JM; Taytard A; Hanard T; Noseda G; Mancini C
Int J Clin Pharmacol Ther; 1995 Nov; 33(11):612-8. PubMed ID: 8688986
[TBL] [Abstract][Full Text] [Related]
4. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
5. Erdosteine.
Dechant KL; Noble S
Drugs; 1996 Dec; 52(6):875-81; discussion 882. PubMed ID: 8957158
[TBL] [Abstract][Full Text] [Related]
6. Erdosteine for COPD exacerbations.
Drug Ther Bull; 2008 Oct; 46(10):79-80. PubMed ID: 18832259
[TBL] [Abstract][Full Text] [Related]
7. Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent.
Cazzola M; Page C; Rogliani P; Calzetta L; Matera MG
Drugs; 2020 Nov; 80(17):1799-1809. PubMed ID: 33025535
[TBL] [Abstract][Full Text] [Related]
8. Erdosteine: its relevance in COPD treatment.
Moretti M
Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):333-43. PubMed ID: 19331595
[TBL] [Abstract][Full Text] [Related]
9. The protective effect of erdosteine on short-term global brain ischemia/reperfusion injury in rats.
Ozerol E; Bilgic S; Iraz M; Cigli A; Ilhan A; Akyol O
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):20-4. PubMed ID: 18930779
[TBL] [Abstract][Full Text] [Related]
10. Erdosteine ameliorates neurological outcome and oxidative stress due to ischemia/reperfusion injury in rabbit spinal cord.
Ege E; Ilhan A; Gurel A; Akyol O; Ozen S
Eur J Vasc Endovasc Surg; 2004 Oct; 28(4):379-86. PubMed ID: 15350559
[TBL] [Abstract][Full Text] [Related]
11. Health status and costs of exacerbations of chronic bronchitis and COPD: how to improve antibiotic treatment.
Miravitlles M
Expert Rev Pharmacoecon Outcomes Res; 2005 Aug; 5(4):423-35. PubMed ID: 19807260
[TBL] [Abstract][Full Text] [Related]
12. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
Suh DC; Lau H; La HO; Choi IS; Geba GP
Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
[TBL] [Abstract][Full Text] [Related]
13. Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease.
Ruiz-González A; Giménez A; Gómez-Arbonés X; Soler-González J; Sánchez V; Falguera M; Porcel JM
Respirology; 2007 Jan; 12(1):117-21. PubMed ID: 17207036
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant enzymes and melatonin levels in patients with bronchial asthma and chronic obstructive pulmonary disease during stable and exacerbation periods.
Gumral N; Naziroglu M; Ongel K; Beydilli ED; Ozguner F; Sutcu R; Caliskan S; Akkaya A
Cell Biochem Funct; 2009 Jul; 27(5):276-83. PubMed ID: 19475625
[TBL] [Abstract][Full Text] [Related]
15. Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis.
Cazzola M; Calzetta L; Page C; Rogliani P; Matera MG
Pulm Pharmacol Ther; 2018 Feb; 48():185-194. PubMed ID: 29233650
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of a bronchial drainage technique (ELTGOL) in COPD exacerbations.
Kodric M; Garuti G; Colomban M; Russi B; Porta RD; Lusuardi M; Confalonieri M
Respirology; 2009 Apr; 14(3):424-8. PubMed ID: 19192230
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of anti-inflammatory treatment with benacort in exacerbations of chronic obstructive lung disease].
Kolesnikov VV; Korol'chuk IS
Ter Arkh; 2003; 75(1):55-8. PubMed ID: 12652959
[TBL] [Abstract][Full Text] [Related]
18. Erdosteine: antitussive and anti-inflammatory effects.
Dal Negro RW
Lung; 2008; 186 Suppl 1():S70-3. PubMed ID: 18185958
[TBL] [Abstract][Full Text] [Related]
19. Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis.
Ricevuti G; Mazzone A; Uccelli E; Gazzani G; Fregnan GB
Thorax; 1988 Aug; 43(8):585-90. PubMed ID: 3051508
[TBL] [Abstract][Full Text] [Related]
20. [Acetylcysteine in the treatment of severe COPD].
Dekhuijzen PN
Ned Tijdschr Geneeskd; 2006 Jun; 150(22):1222-6. PubMed ID: 16796172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
